Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2026-05-16 @ 5:41 PM
Study NCT ID:
NCT05075603
Status:
COMPLETED
Last Update Posted:
2025-10-23
First Post:
2021-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy
Sponsor:
NeoImmuneTech
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Refractory Diffuse Large B-cell Lymphoma | View |
| None | Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | View |
| None | Recurrent Diffuse Large B-Cell Lymphoma | View |
| None | Refractory High Grade B-Cell Lymphoma | View |
| None | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | View |
Keywords: